Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001655970-16-000002
Filing Date
2016-03-17
Accepted
2016-03-17 11:12:43
Documents
1
Effectiveness Date
2016-03-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11352
  Complete submission text file 0001655970-16-000002.txt   12414
Mailing Address 419 DAVIS DRIVE SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE SUITE 100 MORRISVILLE NC 27560 919.973.1440
Envisia Therapeutics, Inc. (Filer) CIK: 0001655970 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-259444 | Film No.: 161511673